PURCHASE AGREEMENTPurchase Agreement • May 1st, 2006 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 1st, 2006 Company Industry Jurisdiction
6,130,000 Shares SONUS PHARMACEUTICALS, INC. Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • May 1st, 2006 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 1st, 2006 Company Industry JurisdictionSonus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to certain investors (collectively, the “Investors”) up to an aggregate of 6,130,000 shares (the “Shares”) of the Company’s Common Stock, par value $.001 per share (the “Common Stock”). The Company desires to engage Needham & Company, LLC as its exclusive lead placement agent (the “Lead Placement Agent”) and Punk, Ziegel & Company, L.P. and ThinkEquity Partners LLC as its exclusive co-placement agents (the “Co-Placement Agents” and, together with the Lead Placement Agent, the “Placement Agents”) in connection with the issuance and sale of the Shares. The Shares are described more fully in the Prospectus (as defined below).